Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML) Meeting Abstract


Authors: Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; Schulman, J.; Glass, J. L.; Taylor, J.; Viny, A. D.; Getta, B.; Arcila, M. E.; Levine, R. L.; Shaffer, B. C.; Gyurkocza, B.; Papadopoulos, E. B.; Perales, M. A.; Papaemmanuil, E.; Giralt, S.; Zhang, Y.; Roshal, M.; Tallman, M. S.
Abstract Title: Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
Meeting Title: 60th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 132
Issue: Suppl. 1
Meeting Dates: 2018 Dec 1-4
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2018-11-29
Language: English
ACCESSION: WOS:000454837601001
PROVIDER: wos
Notes: Meeting Abstract: 292 -- Source: Wos